Tireotoksična periodična paraliza: prikaz slučaja by Jadranka Morović-Vergles et al.
Acta clin Croat 2002; 41:99-102 Case Report
99
THYROTOXIC PERIODIC PARALYSIS: A CASE REPORT
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SUMMARY ∑ A case of thyrotoxic periodic paralysis in a 24-year-old male with hyperthyroidism is
presented. Clinical manifestations included progressive symmetrical weakness that led to flaccid
paralysis due to hypokalemia with concurrent thyrotoxicosis. Intravenous administration of potas-
sium chloride resulted in complete regression of the symptoms of muscle weakness and paralysis.
Hypokalemic periodic paralysis is an uncommon complication of thyrotoxicosis, which primarily occurs
in Orientals, with a high male predominance, and has rarely been described in Caucasians.
Key words: Thyrotoxicosis, complications; Hypokalemia, complications; Paralysis, etiology; Case report
Correspondence to: Professor Jadranka MoroviÊ-Vergles, M.D., Ph.D.,
Department of Medicine, Dubrava University Hospital, Avenija Gojka
©uπka 6, HR-10000 Zagreb, Croatia
E-mail: jmorovic@kbd.hr
Received January 18, 2002, accepted April 26, 2002
Introduction
Periodic paralysis is a rare complication of hyperthy-
roidism1. It has been described in diverse racial and eth-
nic groups2-4, predominantly in Oriental and Latin-
American young males5-7. Thyrotoxic periodic paralysis
(TPP) is a disorder characterized by concurrent thyrotoxi-
cosis, hypokalemia and progressive symmetrical weakness
leading to paralysis of extremities and other muscle
groups. In TPP, hypokalemia is usually associated with hy-
pophosphatemia and mild hypomagnesemia4. The patho-
physiology of TPP remains largely unexplained and con-
troversial.
In this report, clinical and biochemical findings in a
young man with hyperthyroidism who experienced three
attacks of periodic paralysis are described. All three attacks
occurred during or shortly after sleep. The first two attacks
of muscle weakness required no medical intervention and
resolved spontaneously. On the third attack, however, the
patient was admitted to the hospital for complete muscle
paralysis, which regressed upon intravenous administra-
tion of potassium chloride. The attacks of TPP ceased
completely with resolution of the hyperthyroidism.
Case Report
A 24-year-old male was admitted to the Emergency
Unit for myalgia and abrupt onset of tetraparesis after
several hours of sleep. History data revealed similar attacks
to have occurred on two occasions in the past four months,
during the night or at dawn, which spontaneously re-
gressed within a few hours. The patient had not been
hospitalized before. Six months before, the patient had
experienced tremor of his hands, hyperhidrosis, palpita-
tions, nervousness, and hyperorexia with weight loss.
Three months after the onset of these symptoms, the di-
agnosis of hyperthyroidism was made and therapy with
metamizole was initiated. After seven days, this therapy
had to be discontinued due to pronounced side effects
(polyarthralgia, myalgia, generalized urticaria), and pro-
pylthiouracil was introduced, which was well tolerated by
the patient. The patient had normal appetite, normal uri-
nation, and frequent evacuation (up to 4 loose stools
daily). He smoked about 20 cigarettes a day, and used no
alcohol drinks.
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On examination at the Emergency Unit, the patient
was immobile due to tetraparesis, conscious, moist skin,
afebrile, eupneic. There were no cranial nerve symptoms.
The thyroid was enlarged and insensitive on inspection
and palpation. Rhythmical heart action, c/p 96/min, blood
pressure 130/80 mm Hg. Normal respiratory sound over
the lungs. The abdomen soft, insensitive on palpation, no
organomegaly. Mild edema of the metacarpophalangeal
articulation I. Flaccid tetraparesis.
Laboratory findings on admission: one-hour erythro-
cyte sedimentation rate (ESR) 3; complete blood count
(CBC), blood glucose (BG), creatinine, transaminases,
bilirubin, creatine phosphokinase (CPK), and lactic de-
hydrogenase (LDH) were normal; potassium (K) 1.5
(normal range 4.1 ∑ 5.5) mmol/L.
Laboratory findings during hospitalization: phospho-
rus (P) 2.11 (0.65 ∑ 1.62) mmol/L; magnesium (Mg) 0.62
(0.45 ∑ 1.15) mmol/L; calcium (Ca) 2.52 (2.25 ∑ 2.75)
mmol/L; chloride (Cl) 101 (95 ∑ 105) mmol/L. Electro-
lytes in 24-hour urine: potassium (K) 140 (60 ∑ 80) mmol/
DU.
Arterial blood gases and acid ∑ base balance were within
the normal range. Urine: pH 5.0; specific weight 1.025;
sediment normal; 24-hour urine protein negative. Thyroid
hormones: thyroxine (T4) 185 (71 ∑ 141) nmol/L; triiodot-
hyronine (T3) 8.1 (1.5 ∑ 2.6) nmol/L; thyroid-stimulating
hormone (TSH) <0.02 (0.27 ∑ 4.68) mU/L, indicating
hyperthyroidism. Cortisol, aldosterone and plasma renin
activity were within the reference values. Waaler-Rose, la-
tex and dsDNA tests were negative. Thyroid ultrasonog-
raphy (US) indicated diffuse goiter; computed tomography
(CT) of adrenal glands showed no pathologic alterations;
upper abdomen US was normal; electromyoneurography
(EMNG) of upper and lower extremities revealed no myo-
pathic cause; gastroscopy and rectoscopy yielded normal
findings, and so did stool parasitology and bacteriology.
Upon admission, the patient received 40 mmol potas-
sium chloride i.v., which resulted in complete regression
of tetraparesis. The treatment of hyperthyroidism was
continued by propylthiouracil. On control outpatient ex-
aminations after restitution of euthyroidism, the patient
was subjectively well, free from TPP attacks, and with
normal serum potassium values.
Discussion
Most common clinical manifestations of hypokalemia
(serum potassium <3.5 mmol/L) include neuromuscular
(muscle weakness, rhabdomyolysis, ileus), cardiovascular
(ventricular arrhythmias, hypotension, arrest), renal (poly-
uria, nocturia), and metabolic (hyperglycemia) distur-
bances. Hypokalemia can be induced by various causes: 1)
reduced potassium intake (anorexia nervosa, deficient
nutrition in alcoholics); 2) gastrointestinal losses (vomit-
ing, diarrhea, laxative abuse, fistulas, villous adenoma,
ureterosigmoidostomy); 3) intracellular potassium shift
(metabolic alkalosis, insulin and adrenergic agonist over-
dosage, hypokalemic periodic paralysis, theophylline,
barium and toluene intoxication); 4) renal losses (diuret-
ics, aminoglycosides, penicillin antibiotics, primary and
secondary hyperaldosteronism, Bartter’s syndrome, exces-
sive intake of exogenous mineralocorticoids, Cushing’s
syndrome, ectopic ACTH secretion, renal tubular acido-
sis, leukemias, magnesium depletion); and 5) some heredi-
tary disorders (familial hypokalemic periodic paralysis,
congenital androgenital syndrome, Little’s disease, familial
interstitial nephritis).
We have presented a 24-year-old man admitted to the
Department of Medicine Emergency Unit and transferred
to the ward for tetraplegia associated with pronounced
hypokalemia (potassium level, 1.5 mmol/L). Hyperthy-
roidism had been diagnosed on an outpatient basis three
months before the present admission, and the patient
sustained episodes of muscle weakness progressing to
complete paralysis of the extremities on three occasions.
The attacks occurred immediately after sleep and re-
gressed spontaneously in several hours on two occasions.
The third attack, which occurred following discontinua-
tion of metamizole therapy, required medical attention
and the patient was admitted to our emergency room. On
his presentation to the emergency room, the diagnosis of
thyrotoxic periodic paralysis was initially failed, however,
the accurate diagnosis of thyrotoxic hypokalemic periodic
paralysis (THPP) was subsequently made. THPP is a rare
complication that sporadically occurs, mostly in young
males of Asian and Latin-American origin2,4-7, and con-
siderably less commonly in Caucasians and blacks3,8-10.
According to the literature data available, the incidence
of THPP in hyeperthyroidism patients ranges from 0.1%
- 0.2% in American Caucasians10 to 4.3% in Japanese5 .
The male to female ratio is 20:15.
Clinically, THPP cannot be differentiated from famil-
ial periodic paralysis, although the former predominantly
affects males, rarely is associated with positive family his-
tory, and develops later in life. There was no case of peri-
odic paralysis among close relatives of our patient. The
initial clinical manifestations of THPP include myalgia
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and progressive muscle weakness with exacerbation to pa-
ralysis of the extremities. Laboratory findings show hy-
pokalemia (100%), hypophosphatemia (80%), and mild
hypomagnesemia4. Rebound hyperkalemia occurs in some
40% of patients4. In our patient, marked hypokalemia was
corrected by 40 mmol potassium chloride i.v. (the levels
of magnesium and phosphorus were not determined in
Emergency Room). On day 2 of admission, however, the
levels of potassium and magnesium were within the nor-
mal limits. The finding of mild hyperphosphatemia, re-
corded on day 2 of admission, is consistent with literature
data on mild to moderate hypophosphatemia being re-
corded when phosphorus was determined within 1.5 hour
from admission to hospital, or while the level of potas-
sium was still low; upon paralysis resolution, the level of
phosphorus returned to normal or was slightly elevated4.
THPP usually occurs in patients with Graves’ disease,
however, any cause of hyperthyroidism including exces-
sive use of a substitute may lead to this disorder. The clini-
cal and laboratory parameters of hyperthyroidism may be
latent or very discrete. In our patient, hyperthyroidism was
diagnosed three months before his admission to the De-
partment and showed overt clinical manifestations. The
attacks of periodic paralysis, such as those that occurred
in our patient, may be precipitated by the rest (sleep). TPP
attacks after several hours of sleep are usually preceded by
extreme physical activity or excessive carbohydrate in-
take10. Attacks of periodic paralysis may (although not
always) be experimentally induced by a provocation test
with glucose (3 g/kg) and insulin (0.1 IU/kg i.v.)11.
Pathophysiologically, various attempts have been
made to explain THPP, e.g., by the intracellular shift of
potassium due to thyroxine-stimulated enhancement of
K-Na ATP-ase activity on cellular membrane, or by dy-
namic disturbances, or by some morphological features of
the neuromuscular unit itself2,12.
Light microscopy of the muscle biopsy specimens re-
vealed changes in terms of sarcolemmic nuclear prolifera-
tion, muscle fiber atrophy, fatty infiltration and vacuola-
tion, while no changes could be detected in one fourth of
patients. Electron microscopy generally showed vacuola-
tion (90%), mitochondrial abnormalities (100%), accumu-
lation of glycogen granules (100%), myofibril interruption
(50%), and T-system changes (40%). These alterations did
not correlate with the severity of muscle weakness13. In
our patient, EMNG of both upper and lower extremities
showed no deviations from normal, thus muscle biopsy
was not considered necessary. Quadriplegia was promptly
reversed by correction of hypokalemia (40 mmol potas-
sium chloride administered as 2-hour i.v. infusion). Dur-
ing the first few days of his hospital stay, renal loss of
potassium (hyperkaluria) was recorded, along with clini-
cally and laboratory overt hyperthyroidism. Serum and
urine values of other electrolytes, as well as blood pressure,
diuresis, arterial blood pH, urine pH, specific weight and
sediment, cortisol, aldosterone and plasma renin activity
were within the normal limits. The finding of transitory
hyperkaluria could not be explained (the increased intra-
cellular concentration of potassium in the main cells of the
renal collecting ducts may stimulate its secretion by elec-
trochemical gradient through specific potassium channels
in the luminal membrane), however, the available litera-
ture provides no data on transient hyperkaluria following
THPP attack. Our patient did not develop rebound hy-
perkalemia after parenteral potassium substitution (per-
haps just these patients experiencing transient hyperkalu-
ria after THPP attack and substitution therapy with po-
tassium are not prone to the development of rebound
hyperkalemia!?). The episodes of paralysis are reduced by
potassium substitution, and attacks can be prevented by
the administration of beta-blockers, potassium substitu-
tion and spironolactone until restitution of euthyroidism8.
Definitive treatment of thyrotoxic periodic paralysis
should be directed at the establishment of euthyroid state,
and it is usually sufficient to prevent the occurrence of
spontaneous attacks. Indeed, in our patient, serum levels
of potassium normalized with the introduction of propy-
lthiouracil and restitution of euthyroidism, even without
potassium substitution and with no record of hyperkaluria.
Conclusion
On differential diagnosis, thyrotoxic hypokalemic pe-
riodic paralysis should be considered in any acute episode
of motor paralysis in young patients, especially males.
Although the pathogenesis of this dramatic disorder has
not yet been fully elucidated, and the reason for sexual and
racial predisposition remains unknown, there is strong
evidence that successful therapy for hyperthyroidism leads
to regression of all clinical and laboratory parameters of
the disorder, as also observed in our patient. This is a typi-
cal case of thyrotoxic periodic paralysis in an epidemio-
logical group which, to our knowledge, has not yet been
described.
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Saæetak
TIREOTOKSI»NA PERIODI»NA PARALIZA: PRIKAZ SLU»AJA
J. MoroviÊ-Vergles, B. OstriËki, K. GaleπiÊ, M. ©koro i D. Zelenika
U radu je prikazan 24-godiπnji muπkarac s napadajem periodiËne paralize u hipertireozi. Prikazan je bolesnik s progresivnom
simetriËnom slaboπÊu koja je dovela do mlohave paralize uslijed hipokalijemije tijekom tireotoksikoze. Nakon parenteralnog
dodatka kalija (intravenskom primjenom kalijevog klorida) doπlo je do potpunog povlaËenja simptoma miπiÊne slabosti i
paralize. HipokalijemiËna periodiËna paraliza rijetka je komplikacija tireotoksikoze opisana u stanovnika Dalekog Istoka, i to
prvenstveno u mlaih muπkaraca, a iznimno se rijetko javlja u bijelaca.
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